Keck School of Medicine, University of Southern California

Los Angeles, California 90033

4 studies enrolling now · 20 studies all time

What they study most

Air Pollution, Alcohol, Alcohol Use Disorder, Amyotrophic Lateral Sclerosis, Atherosclerosis, Atopic Dermatitis, Burnout, C3 Glomerulonephritis, C3 Glomerulopathy, C3G, Cardiometabolic Health, Chronic Hepatitis C

Studies at this site

• Multi-Site Trial of Tirzepatide for Smoking Cessation — Recruiting now
• Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History — Recruiting now
• Tirzepatide for Alcohol Use Disorder — Recruiting now
• HEPA, PM2.5, and Cardiometabolic Health — Recruiting now
• Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN — Completed
• Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis — Completed
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• Keck Medicine of University of Southern California Thrive Study — Status unconfirmed
• A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA) — Completed
• A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) — Stopped early
• A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis — Stopped early
• A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis — Completed
• Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis. — Completed
• A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) — Completed
• Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS) — Stopped early
• Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion — Status unconfirmed
• NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction — Completed
• Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2) — Completed
• Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG) — Completed
• Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive — Completed